| GCC | Gulf Cooperation Council |
| ADT | Androgen Deprivation Therapy |
| LHRH | Luteinizing Hormone Releasing Hormone |
| ARPI | Androgen Receptor Pathway Inhibitor |
| MDT | Metastasis Directed Therapy |
| SBRT | Stereotactic Body Radiotherapy |
| PSMA | Prostate-Specific Membrane Antigen |
| PET-CT | Positron Emission Tomography—Computed Tomography |
| MRI | Magnetic Resonance Imaging |
| RECIP | Response Evaluation Criteria in PSMA Imaging |
| CR | Complete Response |
| PR | Partial Response |
| SD | Stable Disease |
| PD | Progressive Disease |
| CTCAE | Common Toxicity Criteria for Adverse Events |
| PSA | Prostate Specific Antigen |
| IQR | Interquartile Range |
| BRCA | Breast Cancer Gene |
| GU | Genito-urinary |
| GI | Gatro-intestinal |